GLGC
Thursday May 21, 7:24 pm Eastern Time
Company Press Release
Biotech Stocks Have Incredible Future And Hold Big
Risks, T. Rowe Price Analyst Jenner Advises Investors
BETHESDA, Md.--(BW HealthWire)--May 21, 1998--Biotechnology stocks have an incredibly
bright future, but with the potentially lucrative rewards come high levels of financial risk, a noted
industry expert advises individual investors.
''There is no doubt in my mind that the fundamentals are in place for certain biotechs to do very well
in the future. We as a firm are committed to the sector,'' said Kris Jenner, M.D., Ph.D., Health Care
Analyst with T. Rowe Price Associates (NASDAQ:TROW - news), in an interview. ''But while the
future has never looked brighter, investors need to approach biotechs with a great deal of caution.''
Jenner joins Dr. Alexander Arrow, Vice President/Research at Wedbush Morgan Securities, Los
Angeles, as keynote speakers at the First Annual Informed Investors Beltway Biotechnology Stocks
Forum Saturday June 6 at the Hyatt Regency Bethesda. In addition to the two biotech industry
experts, attendees will hear from top executives of up to eight biotech companies. Ones already
committed to presenting are: Gene Logic (NASDAQ:GLGC - news), |
